Preview Mode Links will not work in preview mode

This Week in Cardiology

Nov 3, 2023

Tricuspid regurgitation therapy, two more left atrial appendage trials, and reflections on being too soft on medical science are the topics John Mandrola, MD, discusses in this week’s podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. Tricuspid Regurgitation

Trilogy TAVR Safe, Effective in Aortic Regurgitation

The TRILUMINATE Transcatheter Tricuspid Repair Trial: Positive but No Benefit?

Transcatheter Tricuspid Valve Repair Effective, Safe for Regurgitation: TRILUMINATE


II. LAA Occlusion

Different Strengths for LAA Closure Devices?

- Swiss Apero – Original paper

- Swiss Apero – One-year

Peri-device Leaks After Watchman

TAVR With Left Atrial Appendage Occlusion Non-inferior to TAVR Plus Medical Therapy


You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact